全球新生儿癫痫药物市场 – 行业趋势和 2029 年预测

市场分析和规模

由于可用于帮助确定适合所有年龄段患有各种类型癫痫的儿童使用药物的证据有限，医生在治疗癫痫儿童时面临着独特的问题。然而，最近在了解如何使用抗癫痫药物 (AED) 治疗新生儿癫痫和婴儿痉挛（即发生在生命第一年的癫痫症）方面取得了进展。AED 在治疗这些疾病方面的疗效一直存在争议，预测每个孩子这些问题的命运一直具有挑战性，因此任何进展都是受欢迎的。

Data Bridge Market Research 分析称，新生儿癫痫药物市场在 2021 年的价值为 2.225 亿美元，预计到 2029 年将达到 2.9073 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 3.40%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

Market Definition

Seizures in neonates are aberrant electrical discharges in the central nervous system that typically appear as stereotyped muscle activity or autonomic abnormalities. Electroencephalography confirms the diagnosis, and further testing for reasons is recommended. Treatment is determined by the underlying cause. Seizures affect up to 1.4 percent of full-term new-borns and 20% of premature infants. Seizures could be a sign of a significant neonatal condition that has to be evaluated right away. The lack of myelination and insufficient creation of dendrites and synapses in neonates prevents generalization of electrical activity, hence most neonatal seizures are focal.

Neonatal Seizures Drugs Market Dynamics

Drivers

• Increasing prevalence of hypoxia-ischemia

The rising prevalence of hypoxia-ischemia is anticipated to influence the neonatal seizures drugs? market's growth. The most prevalent cause of neonatal seizures is hypoxia-ischemia, which can occur before, during, or after delivery. Seizures of this nature can be severe and difficult to treat, but they usually subside after 3 to 4 days. Seizures may be less severe when new-born hypoxia is treated with therapeutic hypothermia (typically whole-body chilling), although they may recur upon rewarming.

• Rising incidences of neonatal infections

The increasing incidences of neonatal infections is expected to flourish the market's growth rate during the forecast period of 2022-2029. Seizures can occur as a result of neonatal infections including meningitis and sepsis; in these cases, seizures are usually accompanied by other symptoms and signs. In neonates, group B streptococci and gram-negative bacteria are the most common causes of infection. Seizures can also be caused by encephalitis caused by the cytomegalovirus, herpes simplex virus, rubella virus, Treponema pallidum, Toxoplasma gondii, or Zika virus.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the neonatal seizures drugs? market. Additionally, rising healthcare expenditure and changing lifestyle of people will result in the expansion of neonatal seizures drugs? market. Along with this, rising prevalence rate of chronic disease such as thyroid, diabetes, and kidney disease, and favourable reimbursement policies will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the neonatal seizures drugs? market growth. Along with this, rising drug approvals and launches will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of neonatal seizures drugs during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution? will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the neonatal seizures drugs? market. Additionally, the side effects of neonatal seizures drugs? will act as market restrain and further impede the market's growth rate during the forecast period of 2022-2029.

This neonatal seizures drugs? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neonatal seizures drugs? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Seizures in new-borns are a common neurological emergency. In terms new-borns, the incidence has been reported to range from 1 to 5.5 per 1000 live births, with greater rates recorded in preterm infants. In the United States, the incidence is estimated to be between 80 and 120 instances per 100,000 new-borns per year.

Neonatal seizures drugs? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Neonatal Seizures Drugs Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. This can be ascribed to severe disruptions in their respective manufacturing and supply-chain operations, resulting from multiple precautionary lockdowns and other limitations imposed by governments all over the world. The neonatal seizures drugs market was no exception. Furthermore, consumer preferences has decreased as people are now much more concentrated on removing non-essential expenses from their budgets as the wider economic situation of most people has been adversely impacted by this outbreak. Over the forecast period, the aforementioned factors were likely to have a negative impact on the neonatal seizures drugs market's revenue trajectory. However, now that COVID-19 vaccines are readily available, numerous authorities are trying to assure that life-saving medications and vaccines are supplied without interruption. As a result, the market is projected to stabilize in the future.

Global Neonatal Seizures Drugs Market Scope

The neonatal seizures drugs? market is segmented on the basis of type, drug, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Tonic Seizures
• Clonic and Myoclonic Seizures
• Non Paroxysmal Repetitive Behaviours

Drug

• Dilantin
• Phenobarbital
• Other

Dosage

• Injection
• Tablets
• Others

Route of Administration

• Oral
• Parenteral
• Others

 End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Neonatal Seizures Drugs Market Regional Analysis/Insights

The neonatal seizures drugs? market is analysed and market size insights and trends are provided by country, type, drug, dosage, route of administration, end-users and distribution channel as referenced above.

新生儿癫痫药物市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区（中东和非洲的一部分）、巴西、阿根廷和南美洲的其他地区（南美洲的一部分）

北美在新生儿癫痫药物市场占据主导地位，因为该地区对研发活动的投资不断增加。此外，主要关键参与者的不断增加和完善的医疗保健基础设施将进一步推动该地区市场的增长率。

由于医疗保健支出增加和医疗保健基础设施改善，预计亚太地区在 2022-2029 年预测期内将实现增长。此外，肾脏疾病、甲状腺和肝脏疾病患病率的激增以及仿制药数量的增加将进一步推动该地区市场的增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和新生儿癫痫药物市场份额分析

新生儿癫痫药物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对新生儿癫痫药物市场的关注有关。

新生儿癫痫药物市场的一些主要参与者是：

• 默克集团（德国）
• 卫材株式会社（日本）
• 阿斯利康（英国）
• 赛诺菲（法国）
• 诺华公司（瑞士）
• 雅培（美国）
• F. Hoffmann-La Roche Ltd.（瑞士）
• Teva Pharmaceutical Industries Ltd.（爱尔兰）
• 辉瑞公司（美国）
• 葛兰素史克公司 (英国)
• 沃克哈特（孟买）
• 诺和诺德公司（丹麦）
• Glenmark 制药有限公司（印度）
• Cipla Inc.（美国）
• Bausch Health Companies Inc.（加拿大）
• 大冢美国制药公司（美国）
• 强生私人有限公司（美国）
• 武田药品工业株式会社 (日本)
• 住友公司（日本）
• Biocon（印度）  

SKU-56594